2023. Cell division cycle 42 effector protein 4 inhibits prostate cancer progression by suppressing ERK signaling pathway. Biomolecules and Biomedicine. (Dec. 2023), 796–803. DOI:https://doi.org/10.17305/bb.2023.9986.